Clinical Trials on Glucose Intolerance in Portugal
Total 94 results
-
Instituto Politécnico de BragançaRecruiting
-
Universidade do PortoUnknown
-
Universidade do PortoNOVA Medical School; Center for Health Technology and Services ResearchUnknownDiabetes Mellitus, Type 2Portugal
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Federação Portuguesa de FutebolRecruitingHealthy | Craving | Postprandial Hyperglycemia | Nutrition, Healthy | HungerPortugal
-
Universidade do PortoFederation Internationale de Football Association; Administração Regional de... and other collaboratorsCompletedDiabetes Mellitus, Type 2Portugal
-
Associacao Protectora dos Diabeticos de PortugalMedtronicCompletedDiabetes Mellitus, Type 2Portugal
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
-
Universidade Nova de LisboaUnknownType 2 DiabetesPortugal
-
Universidade do PortoUnidade de Saúde Familiar Homem do Leme; Health4All Primary Healthcare Research... and other collaboratorsRecruiting
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
-
Instituto Politécnico de BragançaEuropean Social Fund; Unidade Local de Saúde do NordesteEnrolling by invitation
-
Universidade do PortoCompletedMetabolic Syndrome | Obesity, AdolescentPortugal
-
Universidade Nova de LisboaRecruitingType 1 DiabetesPortugal
-
Universidade do PortoFundação para a Ciência e a Tecnologia; University Institute of MaiaCompletedDiabetes Mellitus, Type 2 | Hypoxia | Exercise | CarbohydratePortugal
-
Faculdade de Motricidade HumanaFundação para a Ciência e a TecnologiaNot yet recruitingDiabetes Mellitus, Type 2Portugal
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Association for Innovation and Biomedical Research...Fundação para a Ciência e a TecnologiaCompletedNPDR - Non Proliferative Diabetic RetinopathyPortugal
-
Iolanda Costa GalinhaDGArtes - Direção Geral das Artes; CIS-Iscte - Centro de Investigação e Intervenção...CompletedDepression | Quality of Life | Body Weight | Stress | Sleep | Anxiety | Blood Pressure | Cognitive Function | Blood Glucose | Loneliness | Physical Function | Medication Compliance | Balance | Memory | Biomarker | Well-Being | Respiratory Function | Social Identification | Cholesterol | C-reactive Protein | Erythrocyte Sedimentation Rate and other conditionsPortugal
-
Association for Innovation and Biomedical Research...Fundação para a Ciência e a TecnologiaCompleted
-
Universidade do AlgarveUniversity of Huelva; OKM Química Ortopédica S.L.; Lola - J. Andrade Ferreira... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Diabetic Peripheral NeuropathyPortugal
-
European Vision Institute Clinical Research NetworkCompletedType 2 Diabetes | Non Proliferative Diabetic RetinopathyPortugal
-
Association for Innovation and Biomedical Research...CompletedDiabetes Mellitus Type II | Diabetes Mellitus Type I | High Risk Proliferative Diabetic RetinopathyPortugal
-
Universidade do PortoMerck Serono International SA; Centro Hospitalar de Vila Nova de Gaia/EspinhoCompletedInsulin Resistance | Metabolic Syndrome X | Diastolic DysfunctionPortugal
-
Juvantia Pharma LtdSanthera PharmaceuticalsUnknownParkinson's Disease | Multiple System Atrophy | Symptomatic Neurogenic Orthostatic Hypotension (NOH)France, Portugal
-
Hospital de Sao SebastiaoInstituto de Ciências Biomédicas Abel Salazar; The Novo Nordisk Foundation...Active, not recruitingObesity | Diabetes Mellitus, Type 2Portugal
-
AstraZenecaCompletedDiabetes Type 2Portugal
-
Biotronik SE & Co. KGCompletedSyncopeFrance, Spain, Italy, Netherlands, Canada, Portugal
-
Association for Innovation and Biomedical Research...CompletedType 2 Diabetes Mellitus | Mild Nonproliferative Diabetic RetinopathyPortugal, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1United Arab Emirates, Saudi Arabia, Portugal
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkActive, not recruitingDiabetes Mellitus, Type 2 | Retinal Disease | NPDR - Non Proliferative Diabetic RetinopathyFrance, Italy, Portugal
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael, Spain, China, Turkey, Germany, Poland, Italy, Canada, Portugal
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Argentina, Portugal, South Africa
-
PerspectumKing's College Hospital NHS Trust; University of Coimbra; Liverpool University... and other collaboratorsCompletedMetabolic Syndrome | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited Kingdom, Germany, Netherlands, Portugal
-
Associacao para Investigacao e Desenvolvimento...AstraZeneca; Cardiovascular Centre of the University of Lisbon (CCUL)Active, not recruitingCoronary Heart Disease | Type2 Diabetes MellitusPortugal
-
SanofiCompletedDiabetes Mellitus, Type 2France, Spain, Italy, Belgium, Germany, Poland, Portugal, Czech Republic, Slovakia, Australia, Netherlands, Sweden, United Kingdom, Switzerland, Romania
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Theravance BiopharmaTerminatedSymptomatic Neurogenic Orthostatic HypotensionUnited States, Spain, Portugal, United Kingdom, France, Denmark, Ukraine, Israel, Estonia, Poland, Italy, Russian Federation, Australia, Austria, Bulgaria, Canada, Germany, New Zealand
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Czechia, Portugal, Hungary, Germany, Poland
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Netherlands, United Kingdom, Czechia, Portugal, Hungary
-
Theravance BiopharmaCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Austria, Greece, Hungary, Japan, Portugal, Romania, Spain
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, United Kingdom, Portugal, Spain, Netherlands, Croatia, Slovenia, Greece, Italy, Germany, Romania, Russian Federation
-
PfizerTerminatedDiabetes Mellitus, Type 1Denmark, Spain, Sweden, United States, Belgium, Austria, France, Portugal, Ireland, United Kingdom, Finland, Netherlands, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, India, Malaysia, Turkey, Argentina, Greece, Australia, Portugal, Thailand, Brazil
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Germany, Italy, Puerto Rico, Hungary, Mexico, United States, India, Portugal, Taiwan, Brazil, Poland